Skip to content
ppharmaranks
Menu
CompaniesProductsDrug classesConditionsBest by conditionTreatmentsInteraction checkerFood & medicinesWhat pharmacies payPill identifierMedicines & breastfeedingChildren’s dosage chartsDo medicines expire?Crushing & splitting pillsHow long meds take to workAlternating Tylenol & ibuprofenDrug recallsSupplementsSafety & lawsuitsGuidesA–ZHow we rate

BLENREP vs SARCLISA ESCENA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated October 7, 2026·How we rate

Possible drug interaction. BLENREP and SARCLISA ESCENA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

blenrepsarclisa escena

Rating

72/100
72/100

Pharmacy pays

—
—

Type

RX
RX

Active ingredient

BELANTAMAB MAFODOTIN-BLMF
ISATUXIMAB-IRFC

Manufacturer

Glaxosmithkline
Sanofi-Aventis U.S. LLC

Dosage forms

Injectable
Injectable

Drug class

—
—

Boxed warning

Boxed warning
None

Treats

Multiple Myeloma
Multiple Myeloma

Frequently asked questions

Which is better-rated, Blenrep or Sarclisa Escena?

Blenrep and Sarclisa Escena are tied at 3.6 out of 5 by our independent rating.

What is the difference between Blenrep and Sarclisa Escena?

Blenrep contains Belantamab Mafodotin-Blmf, while Sarclisa Escena contains Isatuximab-Irfc — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.